Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

SHE/002007 stock hub

SHE/002007 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SHE/002007is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

26.6B

Shenzhen Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SHE/002007

In the news

Latest news · SHE/002007

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E26.4

P25 17.1P50 24.2P75 37.8

Trailing P/E31

P25 23.5P50 41.3P75 83.2

ROE6.6

P25 -0.9P50 4.1P75 8.8

ROIC9.1

P25 -0.5P50 5P75 11.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SHE/002007 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

243

Groups with data

Currency

CNY

Showing 243 of 243 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	CN
Employees	4,117
Employees Change	105%
Employees Change Percent	2.62
Enterprise value	CNY 24.7B
Exchange	Shenzhen Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Biotechnology
Isin	CNE000001JN8
Last refreshed	2026-05-10
Market cap	CNY 26.6B
Price	CNY 14.54
Price currency	CNY
Rev Per Employee	1,090,482.5x
Sector	Healthcare
Sic	2836
Symbol	she/002007
Website	https://www.hualanbio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.23%
EV Earnings	28.83x
EV/EBIT	23.91x
EV/EBITDA	18.85x
EV/FCF	36.57x
EV/Sales	5.51x
FCF yield	2.54%
Forward P/E	26.44x
P/B ratio	1.95x
P/E ratio	30.96x
P/S ratio	5.92x
PE Ratio10 Y	36.7x
PE Ratio3 Y	28.4x
PE Ratio5 Y	30.67x
PEG ratio	2.56x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	23.03%
EBITDA Margin	29.21%
FCF margin	15.06%
Gross margin	55.16%
Gross Profit	CNY 2.5B
Gross Profit Growth	-6.93%
Gross Profit Growth Q	-21.67%
Gross Profit Growth3 Y	-6.04%
Gross Profit Growth5 Y	-7.2%
Net Income	CNY 857.6M
Net Income Growth	-24.72%
Net Income Growth Q	-26.44%
Net Income Growth Years	0%
Net Income Growth3 Y	-10.45%
Net Income Growth5 Y	-11.96%
Pretax Margin	24.02%
Profit Margin	19.1%
Profit Per Employee	CNY 208,310
Profitable Years	25
ROA	4.08
Roa5y	6.27
ROCE	7.53
ROE	6.61
Roe5y	11.65
ROIC	9.12
Roic5y	14.75

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	1.03%
Cagr15y	2.71%
Cagr1y	-8.01%
Cagr20y	15.97%
Cagr3y	-11.43%
Cagr5y	-16.06%
Div CAGR10	13.06%
Div CAGR3	32.64%
Div CAGR5	18.47%
EPS Growth	-24.62
EPS Growth Q	-26.4
EPS Growth Years	0
EPS Growth3 Y	-10.43
EPS Growth5 Y	-12.02
FCF Growth	-16.56%
FCF Growth3 Y	-6.78%
FCF Growth5 Y	-2.42%
OCF Growth	-16.22%
OCF Growth10 Y	4.56%
OCF Growth3 Y	-12.23%
OCF Growth5 Y	-10.53%
Revenue Growth	0.67x
Revenue Growth Q	-12.16x
Revenue Growth Years	1x
Revenue Growth3 Y	-1.91x
Revenue Growth5 Y	-2.01x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CNY 0.28
Assets	CNY 15.1B
Cash	CNY 3.8B
Current Assets	CNY 8.7B
Current Liabilities	CNY 1.3B
Debt	CNY 8.9M
Debt EBITDA	CNY 0.01
Debt Equity	CNY 0
Debt FCF	CNY 0.01
Equity	CNY 13.6B
Interest Coverage	136.1
Liabilities	CNY 1.4B
Long Term Assets	CNY 6.4B
Long Term Liabilities	CNY 101M
Net Cash	CNY 3.8B
Net Cash By Market Cap	CNY 14.14
Net Cash Growth	-24.02%
Net Debt EBITDA	CNY -2.87
Net Debt Equity	CNY -0.28
Net Debt FCF	CNY -5.56
Tangible Book Value	CNY 11.4B
Tangible Book Value Per Share	CNY 6.24
WACC	6.37

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	6.57
Inventory Turnover	0.84
Net Working Capital	CNY 3.6B
Quick ratio	4.44
Working Capital	CNY 7.4B
Working Capital Turnover	CNY 0.58

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.13%
Dividend Growth	0%
Dividend Growth Years	1%
Dividend per share	CNY 1
Dividend Years	17
Dividend Yield	6.88%
Ex Div Date	2025-10-27
Last Dividend	CNY 0.5
Payout Frequency	Annual
Payout Ratio	147.37%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	10.83%
1Y total return	-8%
200-day SMA	15.81
3Y total return	-30.53%
50-day SMA	14.9
50-day SMA vs 200-day SMA	50under200
5Y total return	-58.32%
All Time High	76
All Time High Change	-80.87%
All Time High Date	2020-08-04
All Time Low	0.44
All Time Low Change	3,218.12%
All Time Low Date	2005-06-02
ATR	0.21
Beta	0.38
Beta1y	0.22
Beta2y	0.38
Ch YTD	-3.9
High	14.68
High52	18.39
High52 Date	2025-08-27
High52ch	-20.94%
Low	14.43
Low52	14.14
Low52 Date	2026-03-23
Low52ch	2.83%
Ma50ch	-2.39%
Price vs 200-day SMA	-8.06%
RSI	43.36
RSI Monthly	38.39
RSI Weekly	36.96
Sharpe ratio	-0.57x
Sortino ratio	-0.5
Total Return	7%
Tr YTD	-3.9
Tr15y	49.32%
Tr1m	-1.49%
Tr1w	0.55%
Tr3m	-6.07%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CNY 1B
Operating Income Growth	-17.1
Operating Income Growth Q	-27.08
Operating Income Growth3 Y	-7.79
Operating Income Growth5 Y	-12.26
Operating margin	23.03

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	962,023,177%
Net Borrowing	-1,080,142,004
Shares Insiders	18.47%
Shares Institutions	12.86%
Shares Out	1,827,456,666
Shares Qo Q	0.53%
Shares Yo Y	-0.13%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CNY 676.2M
Average Volume	8,515,492.75x
Bv Per Share	6.41
CAPEX	CNY -181.2M
Ch10y	-3.48
Ch15y	24.56
Ch1m	-1.49
Ch1w	0.55
Ch1y	-11.88
Ch20y	1,446.5
Ch3m	-6.07
Ch3y	-35.49
Ch5y	-61.99
Ch6m	-11.66
Change	0.83%
Change From Open	0.62
Close	14.42
Days Gap	0.21
Depreciation Amortization	277,236,223
Dollar Volume	167,382,764.3
Earnings Date	2026-04-27
EBIT	CNY 1B
EBITDA	CNY 1.3B
EPS	CNY 0.47
F Score	5
FCF	CNY 676.2M
FCF EV Yield	2.73x
FCF Per Share	CNY 0.37
Financing CF	-2,525,155,114
Fiscal Year End	December
Founded	1,992
Graham Number	8.23197
Graham Upside	-43.38
Income Tax	CNY 159.5M
Investing CF	1,454,887,129
Is Primary Listing	1
Last Earnings Date	2026-04-27
Last Report Date	2026-03-31
Last Split Date	2020-04-27
Last Split Type	Forward
Lynch Fair Value	CNY 2.35
Lynch Upside	-83.85
Ma150	15.51
Ma150ch	-6.28%
Ma20	14.74
Ma20ch	-1.36%
Net CF	-212,895,583
Next Earnings Date	2026-08-28
Open	14.45
P FCF Ratio	39.29
P OCF Ratio	30.99
Payment Date	2025-10-27
Position In Range	44
Ppne	2,972,958,134
Price Date	2026-05-08
Price EBITDA	CNY 20.26
Ptbv Ratio	2.33
Relative Volume	1.38x
Revenue	4,489,516,446x
Tax By Revenue	3.55x
Tax Rate	14.79%
Tr20y	1,836.84%
Tr6m	-11.66%
Volume	11,511,882
Z Score	14.22

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

SHE/002007 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+6.9%

$1.00 annual per share

Payout ratio

+147.4%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+18.5%

1 consecutive years of growth

Total shareholder yield

+7.0%

Next ex-dividend date: 2025-10-27

Performance

SHE/002007 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SHE/002007?

Insider, institutional, and short-interest positioning.

Institutional ownership

+12.9%

Share of float held by funds and institutions

Insider ownership

+18.5%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.1%

Negative means the company is buying back shares.

Technical

SHE/002007 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

43.4

Neutral momentum band

Price vs 200-day MA

-8.1%

50/200-day relationship not available

Beta (5Y)

0.38

Less volatile than the market

Sharpe ratio

-0.57

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SHE/002007

Hub-level FAQ points readers to the deeper analysis pages.

What is the current she/002007 stock rating?

she/002007 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full she/002007 analysis?

The full report lives at /stocks/she/002007/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for she/002007?

The latest report frames she/002007 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the she/002007 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.